Clene Inc.
CLNN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001822791
No open-market purchases or sales by Clene Inc. insiders were filed in the last 90 days; 33 institutions reported holding it in 13F filings for Q2 2026, worth $19.6M in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding Clene Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 48 | 53 | +5 |
| Shares | 6.32M | 6.27M | −48.4K (−0.8%) |
| Value | $26.0M | $24.7M | −$1.33M (−5.1%) |
New holders (9)
Institutions that held Clene Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Allspring Global Investments Holdings, LLC | 32,129 | $126.0K | 0.00% |
| Veritable, L.P. | 20,000 | $79.0K | 0.00% |
| Goldman Sachs Group Inc | 17,883 | $70.0K | 0.00% |
| Schonfeld Strategic Advisors LLC | 11,500 | $46.0K | 0.00% |
| Nisa Investment Advisors, LLC | 6,200 | $24.0K | 0.00% |
| Barclays PLC | 3,329 | $13.0K | 0.00% |
| Amalgamated Bank | 3,152 | $12.0K | 0.00% |
| Amalgamated Financial Corp. | 3,152 | $12.0K | 0.00% |
| FMR LLC | 641 | $3.00K | 0.00% |
Sold out (4)
Institutions that held Clene Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Marshall Wace, LLP | 39,039 | $159.0K |
| Susquehanna International Group, LLP | 21,771 | $90.0K |
| Cubist Systematic Strategies, LLC | 15,076 | $62.0K |
| Point72 Hong Kong Ltd | 854 | $4.00K |